Issue link: https://www.e-digitaleditions.com/i/845331
Tablets & Capsules July 2017 15 effect of the CoQ10 due to improved dissolution of the ANI from the SENDS formulation. Vitamin E. This fat-soluble anti-oxidant interrupts the propagation of free radicals in biological membranes and is a necessary dietary component. Julianto et al. conducted a bioavailability study that compared a standard vitamin E softgel against a SENDS formulation of vitamin E [8]. The SENDS formulation was composed of palm oil, an MCT- rich oil, polysorbate 80, and sorbitan oleate. Each formula- tion contained 400 IU of vitamin E. The formulations were evaluated for overall bioavailability in healthy human volun- teers. The SENDS formulation was found to have a higher maximum serum concentration (C max ) and reached it more rapidly (T max ). Furthermore, its bioavailability was nearly three times that of the softgel formulation, as determined by the area under curve (AUC). No significant difference in the elimination half-life of the two formulations was observed. Quercetin. This polyphenolic flavonoid has a wide spectrum of pharmacologic actions, including antiviral, antidiabetic, anti-inflammatory, neuroprotective, and antiproliferative properties. Quercetin exhibits the high- est antiradical properties of all the flavonoids [9]. As such, it is a valuable nutraceutical, however, its low aque- ous solubility limits its therapeutic use. Sanyog et al. studied the effects of both a SENDS formu- lation of quercetin and a formulation of free quercetin on the following: 1) quercetin uptake by caco-2 cells, 2) cell cyto- toxicity, 3) in vivo pharmacokinetics, and 4) ability of quercetin to act as a prophylaxis (administered daily 3 days prior to challenge) and as a therapy (administered immedi- ately after challenge) to inhibit drug-induced toxicity due to the oxidative effects of doxorubicin and cyclosporine A. The SENDS formulation comprised quercetin dissolved into a pre-concentrate composed of 40:40:20 w/w of Capmul MCM (a medium-chain mono- and di-glyceride), polysorbate 20, and ethanol. Capmul MCM was chosen as the primary solubilizer due to its relatively high loading capacity for quercetin (approximately 30 grams per gram). Overall, the SENDS formulation exhibited greater quercetin cell uptake (approximately 24 times higher than free quercetin), no significant cell toxicity compared to free quercetin and quercetin-free pre-concentrate components, significantly increased bioavailability compared to free quercetin, and enhanced cardio-protective (doxorubicin challenge) and nephroprotective (cyclosporine A chal- lenge) activity compared to free quercetin. Conclusion Many ANIs exhibit significant solubility challenges that present a barrier to therapy. SENDS constitute an excel- lent strategy for improving the solubility of these ANIs, thereby increasing their therapeutic utility and efficacy. By dissolving the ANI in an optimized group of pre-concen- trate ingredients, the ANI can be carried in a finely dis- persed oil-in-water emulsion in the aqueous environment of the gastrointestinal tract, leading to increased solubility and absorption. The ANI-containing pre-concentrate can be readily formulated as a liquid, liquid-filled softgel, or

